111523 ⎘
ssRNA viruses positive-sense; Details; Picornaviridae; Enterovirus Viruses as such, e.g. new isolates, mutants or their genomic sequences
Coxsackievirus 83 Vaccine
#2ENCAPSULATED RNA POLYNUCLEOTIDES AND METHODS OF USE
#3DEFECTIVE INTERFERING VIRAL GENOMES
#4GENETICALLY MODIFIED ENTEROVIRUS VECTORS
#5OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
#6OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
#7Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
#8Virus for treatment of tumor
#9Genetically engineered coxsackievirus, and pharmaceutical composition
#10Stable production of virulent enterovirus 71 and use thereof
#11RECOMBINANT ONCOLYTIC VIRUS, SYNTHETIC DNA SEQUENCE, AND APPLICATION THEREOF
#12Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
#13Method for treating cancer with a Coxsackievirus B3 (CVB3) variant
#14Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same
#15Optimized oncolytic viruses and uses thereof
#16Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
#17Gene-modified coxsackievirus
#18Viruses associated with immunodeficiency and enteropathy and methods using same
#19METHODS AND COMPOSITIONS FOR TREATMENT OF HEMATOLOGIC CANCERS
#20NOVEL ATTENUATED POLIOVIRUS: PV-1 MONO-CRE-X
#21Methods and compositions for treatment of hematologic cancers
#22Enterovirus, vaccines, medicaments and diagnostic kits
#23Coxsackievirus A6 strain CVA6-KM-J33 and use thereof